First randomized clinical trial found no harms from dementia screening in primary care

(Regenstrief Institute) In the first randomized controlled trial to evaluate pros and cons of population screening for dementia, Regenstrief Institute and Indiana University School of Medicine researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from screening for Alzheimer's disease and related dementia in diverse rural, suburban and urban primary care clinics.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

Testing for Alzheimer ’s disease and other forms of dementia is hardly foolproof, and could even backfire.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Alzheimer ' s Disease Families and Family Life Memory Elderly Dementia Genetics and Heredity Anxiety and Stress Living Wills and Health Care Proxies Diet and Nutrition Depression (Mental) Frontotemporal Dementia Brain Nursing H Source Type: news
CONCLUSION: The association between Alzheimer's disease pathology and anxiety and apathy is partly due to impairment in cognitive functioning. PMID: 32088096 [PubMed - as supplied by publisher]
Source: Am J Geriatr Psychia... - Category: Geriatrics Authors: Tags: Am J Geriatr Psychiatry Source Type: research
DiscussionWe hypothesize that caregivers in the screening arms will express higher levels of health-related quality of life, lower depressive and anxiety symptoms, and better preparation for caregiving with higher self-efficacy at 24  months. Results from this study will directly inform the National Plan to Address Alzheimer’s Disease, the USPSTF and other organizations regarding ADRD screening and early detection policies.Trial registrationClinicalTrials.gov,NCT03300180. Registered on 3 October.
Source: Trials - Category: Research Source Type: clinical trials
ConclusionsDepression may be an independent factor representing early neurodegeneration in elder patients with MCI. Further studies are warranted to assess whether effective management of NPS promotes the cognitive functions.
Source: The Journal of Nutrition, Health and Aging - Category: Nutrition Source Type: research
Many patients with cognitive impairment have anxiety or depression, but standard treatments are difficult for people with memory issues.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Mental Health and Disorders Depression (Mental) Alzheimer ' s Disease Memory Dementia Psychology and Psychologists Elderly Weill Cornell Medicine your-feed-healthcare Source Type: news
CONCLUSIONS: Use of HAs is associated with delayed diagnosis of AD, dementia, depression, anxiety, and injurious falls among older adults with HL. Although we have shown an association between use of HAs and reduced risk of physical and mental decline, randomized trials are needed to determine whether, and to what extent, the relationship is causal. The Study in Context: Hearing aids, by reducing cognitive load, can improve brain function in persons with hearing loss 46.7 million Americans have Alzheimer’s Disease brain pathology today, so it’s urgent to prevent or at least delay progression to clinical disea...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology anxiety dementia depression fall-related injuries hearing aid hearing loss Medicare older-adults Source Type: blogs
What exactly is psychosis? What happens in the brain of a person with schizophrenia who is hallucinating? Schizophrenic Rachel Star Withers shares her personal hallucinations and delusions and Dr. Joseph Goldberg, who specializes in researching what goes on in the brain when someone is experiencing psychosis, joins to break down how the brain functions during psychotic episodes. Host Rachel Star Withers, a diagnosed schizophrenic, and co-host Gabe Howard delve into these intense subjects in this episode of Inside Schizophrenia.  Highlights from “Psychosis in Schizophrenia” Episode [02:13]  Rachel, do...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Brain and Behavior Disorders General Inside Schizophrenia Mental Health and Wellness Active psychosis Delusions Delusions Hallucinations Living with Schizoprenia Mental Disorder Mental Illness Psychology psychotic Psychotic Break Source Type: blogs
CONCLUSION: We found no evidence that long-term exposure to work-related sleep loss had resulted in cognitive decline or early dementia symptoms in this sample of retired maritime pilots. PMID: 31726459 [PubMed - as supplied by publisher]
Source: Dementia and Geriatric Cognitive Disorders - Category: Psychiatry Tags: Dement Geriatr Cogn Disord Source Type: research
AbstractBackgroundPeople with Alzheimer's disease (AD) often have multimorbidity and take multiple medicines. Yet few studies have examined medicine utilization for comorbidities comparing people with and without AD.ObjectiveThe aim was to investigate the patterns of medication use for comorbidities in people with and without AD.MethodsAn Australian population ‐based study was conducted using the Pharmaceutical Benefits Scheme 10% sample of pharmacy claims data.People with ADwere defined as those dispensed medicines for dementia (cholinesterase inhibitors, memantine, or risperidone for behavioral and psychological sympto...
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Tags: Original Research Article Source Type: research
OBJECTIVE: To examine the association between hearing aids (HAs) and time to diagnosis of Alzheimer disease (AD) or dementia, anxiety or depression, and injurious falls among adults, aged 66 years and older, within 3 years of hearing loss (HL) diagnosis. ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
More News: Alzheimer's | Anxiety | Clinical Trials | Dementia | Depression | International Medicine & Public Health | Primary Care | Rural Health